Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling
KANDA, Rina, KAWAHARA, Akihiko, KUWANO, Michihiko, ONO, Mayumi, WATARI, Kosuke, MURAKAMI, Yuichi, SONODA, Kahori, MAEDA, Masashi, FUJITA, Hideaki, KAGE, Masayoshi, URAMOTO, Hidetaka, COSTA, Carlota
Published in Cancer research (Chicago, Ill.) (15.10.2013)
Published in Cancer research (Chicago, Ill.) (15.10.2013)
Get full text
Journal Article
Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells
Tabara, Keisuke, Kanda, Rina, Sonoda, Kahori, Kubo, Takuya, Murakami, Yuichi, Kawahara, Akihiko, Azuma, Koichi, Abe, Hideyuki, Kage, Masayoshi, Yoshinaga, Aki, Tahira, Tomoko, Hayashi, Kenshi, Arao, Tokuzo, Nishio, Kazuto, Rosell, Rafael, Kuwano, Michihiko, Ono, Mayumi
Published in PloS one (17.07.2012)
Published in PloS one (17.07.2012)
Get full text
Journal Article
Abstract LB-220: The Integrinβ1/Src/Akt-driven bypass signaling pathway contributes to Erlotinib resistance in lung cancer
Ono, Mayumi, Kanda, Rina, Watari, Kosuke, Kawahara, Akihiko, Kage, Masayoshi, Uramoto, Hidetaka, Kuwano, Michihiko
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article